Active Pharmaceutical Ingredient CDMO Market Bolstered by Biologics API Expansion
The global active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) market was valued at USD 118.6 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2030. This growth is driven by several factors, including increased investments in drug research and development, rising rates of chronic...
0 0 Comments 0 Shares